Sintx Technologies (SINT) Consolidated Net Income (2013 - 2026)
Sintx Technologies' (SINT) quarterly Consolidated Net Income came in at -$2.8 million in Q1 2026, down 23.08% year-on-year from -$3.7 million in Q1 2025, and down 27.36% quarter-over-quarter from -$2.2 million in Q4 2025.
Sintx Technologies (SINT) Consolidated Net Income (2013 - 2026) Analysis & Trends
Sintx Technologies' Consolidated Net Income history runs 14 years deep, the most recent figure standing at -$2.8 million for Q1 2026.
- On a quarterly basis, Consolidated Net Income fell 23.08% year-over-year to -$2.8 million in Q1 2026; TTM through Mar 2026 was -$10.9 million, a 12.37% increase from a year earlier, with the FY2025 full-year figure at -$8.2 million, up 21.34% from the prior year.
- Consolidated Net Income eased to -$2.8 million in Q1 2026 per SINT's latest filing, from -$2.2 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at -$293000.0 in Q1 2023 and bottomed at -$6.2 million in Q3 2024.
- The 5-year median for Consolidated Net Income is -$2.5 million (2023), against an average of -$2.6 million.
- Across the five-year window, Consolidated Net Income surged 89.7% in 2023 and tumbled 202.39% in 2024, its largest moves.
- Year by year, Consolidated Net Income stood at -$4.0 million in 2022, then soared by 41.36% to -$2.3 million in 2023, then increased by 26.97% to -$1.7 million in 2024, then slumped by 30.68% to -$2.2 million in 2025, then decreased by 27.36% to -$2.8 million in 2026.
- Per Business Quant, the three latest SINT Consolidated Net Income figures stand at -$2.8 million (Q1 2026), -$2.2 million (Q4 2025), and -$3.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 273.95 Mn |
| 10 | Sintx Technologies | 6.02 Mn | 4.13 Mn | 144,000.00 | -2.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.82 Mn |
| Dec 31, 2025 | -2.22 Mn |
| Sep 30, 2025 | -3.54 Mn |
| Jun 30, 2025 | -2.32 Mn |
| Mar 31, 2025 | -2.29 Mn |
| Dec 31, 2024 | -1.70 Mn |
| Sep 30, 2024 | -6.24 Mn |
| Jun 30, 2024 | -2.20 Mn |
| Mar 31, 2024 | -886,000.00 |
| Dec 31, 2023 | -2.32 Mn |
| Sep 30, 2023 | -3.19 Mn |
| Jun 30, 2023 | -2.46 Mn |
| Mar 31, 2023 | -293,000.00 |
| Dec 31, 2022 | -3.96 Mn |
| Sep 30, 2022 | -2.72 Mn |
| Jun 30, 2022 | -2.51 Mn |
| Mar 31, 2022 | -2.85 Mn |
| Dec 31, 2021 | -2.13 Mn |
| Sep 30, 2021 | -2.34 Mn |
| Jun 30, 2021 | -2.20 Mn |